Pooled platelet concentrates: Maybe not fancy, but fiscally sound and effective

Transfusion Science

Volumn 18, Issue 4, 1997, Pages 575-583

  Sweeney, Joseph D ^a   Petrucci, Jane ^b   Yankee, Ronald ^b  

^a MIRIAM HOSPITAL   (United States)

^b Rhode Island Blood Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOCYTE CONCENTRATE;

APHERESIS; BLOOD COMPONENT THERAPY; BLOOD DONOR; COST BENEFIT ANALYSIS; DECISION MAKING; DEVICE; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE NEED; LEGAL LIABILITY; PHYSICIAN; QUALITY CONTROL; REVIEW; THROMBOCYTE; TISSUE PREPARATION; TREATMENT INDICATION;

EID: 0347071634     PISSN: 09553886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-3886(97)00056-8     Document Type: Editorial

References (27)

1. NIH Consensus Conference: Platelet transfusion therapy. Transfus Med Rev 1987; 3:195-200.
2. Heyman MR, Shiffer CA: Platelet transtusion therapy for the cancer patient. Semin Oncol 1990; 17:198-209.
3. Surgenor DM, Wallace EL, Hao SH, Chapman RH: Collection and transfusion of blood in the United States, 1982-1988. N Engl J Med 1990; 322:1646-1651.
4. Wallace EL, Churchill WH, Surgenor DM: Collection and transfusion of blood and blood components in the United States, 1992. Transfusion 1995; 35:802-812.
5. Devine P, Goldstein R, Linden JV, Postoway N, Hoffstadter LK, Hines DM: Data on apheresis, blood collection and transfusion related activities: statistical analyses of the American Association of Blood Banks institutional membership questionnaires. Transfusion 1996; 36:375-381.
6. Kuriyan M, Opalka A: Leukodepleted platelet apheresis production with a modified COBE Spectra collection protocol. J Clin Apher 1995; 10:85-86.
7. Drew MJ, Hodges J: Research and development in the blood bank: efforts of a hospital donor center to improve efficiency in line leukocyte reduction filters for automated platelet pheresis. J Clin Apher 1995; 10:76-80.
8. Sweeney JD, Holme S, Heaton A: Quality of platelet concentrates. Immun Invest 1995; 24:353-370.
9. Murphy S, Rebulla P, Bertonini F: In vitro assessment of the quality of stored platelet concentrates. Trans Med Rev 1994; 8:29-36.
10. Samaza K: Reports of 335 transfusion associated deaths: 1976-1985. Transfusion 1990; 30:583-590.
11. Morrow IF, Braine HG, Kickler TS, Ness PM, Dick JD, Fuller AK: Septic reactions to platelet transfusions. J Am Med Assoc 1991; 266:555-558.
12. Chiu EKW, Yuen KY, Lie AKW: A prospective study of symptomatic bacteremia following platelet transfusion and its management. Transfusion 1994; 34:950-954.
13. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ, REDS group: The risk of transfusion transmitted viral infections. N Engl J Med 1996; 334:1685-1690.
14. Anderson NA, Gray S, Copplestone JA: A prospective randomized study of three types of plate concentrates in patients with hematological malignance corrected platelet count increments and frequency of non hemolytic febrile transfusion reactions. Trans Med 1996; 6:33-39.
15. Heddle NM, Klama LN, Griffith L: A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions. Transfusion 1993; 33:794-797.
16. Goodnough LT, Rikkell J, 4th, Lazarus H: Prevalence of platelet transfusion reactions before and after implementation of leukocyte-depleted platelet concentrates by filtration. Vox Sanguinis 1993; 65:103-107.
17. Sweeney JD, Holme S, Heaton WAL, Stromberg RR: In vitro and in vivo effects of pre-storage filtration of apheresis platelets. Transfusion 1995; 35:125-130.
18. Sweeney JD, Holme S, Heaton WAL, Nelson E: Leukodepleted platelet concentrates prepared by in filtration of platelet rich plasma. Transfusion 1995; 35:131-136.
19. O'Connell BA, Shiffer CA: Donor selection of alloimmunized patients by platelet crossmatching of random donor platelet concentrates. Transfusion 1990; 30:314-317.
20. Julius CJ, Sytsma SR: Comparison of demographics and motivations of highly committed whole blood and platelet donors. J Clin Apher 1993; 8:82-88.
21. Bloom BS, Hillman AL, Fendrick AM, Schwartz JS: A reappraisal of Hepatitis B virus vaccination strategies using cost-effective analysis. Ann Intern Med 1993; 118:298-306.
22. Wong DK, Cheung AM, O'Rourke K, Naylor CD, Detsky AS, Heathcote J: Effect of interferon treatment in patients with Hepatitis B antigen positive chronic Hepatitis B. Ann Intern Med 1993; 119:110-115.
23. Koretz RL, Abbey H, Coleman E, Gitnick G: Non A, non B post transfusion Hepatitis. Ann Intern Me 1993; 119:110-115.
24. Seeff LB, Buskell-Bales Z, Wright EC: Long term mortality after transfusion associated non A non B Hepatitis. N Engl J Med 1992; 327:1906-1911.
25. Lopez-Plaza I, Weissfeld J, Truilzi DJ: Cost effectiveness of single donor (SD) versus pooled platelet (PD) for avoiding donor exposures in primary coronary arteries bypass grafting (CABG). Transfusion 1996; 36:47S.
26. Bowden RA, Slichter SJ, Seyers M: A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion associated CM infection after bone marrow transplant. Blood 1995; 86:3598-3603.
27. Sowemimo-Coker SO, Brandwein H, Wenz B: Analysis of leukocyte subsets in leukoreduced products. Proc 20th Annual Meeting, MAABB, Towson, MD, April, 1997.